Search Results

Pioneering smart medical device company, Sensome, and world-leading Japanese guidewire company, Asahi Intecc, are announcing a collaboration to develop the next generation Clotild® Smart Guidewire, with Asahi Intecc taking on the manufacturing role for this groundbreaking device destined for the treatment of acute ischemic stroke.

Crystal IS, an Asahi Kasei company, announced the successful serial production of 100 mm diameter single-crystal aluminum nitride substrates with 99% usable area, based on current requirements for UVC LEDs, with manufacturing to take place in the United States.

Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI, a type of sterile water that is used for the preparation of injections.

Generating cutting-edge therapeutics requires precision, safety, and efficiency from manufacturing equipment.

Asahi Kasei Corp. announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas.

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, and Asahi Intecc Co., a leading Japanese medical device manufacturer, announced that they will collaborate to introduce Penumbra’s Indigo™ Aspiration System into the Japanese market upon regulatory approval.

The Japanese technology company Asahi Kasei is further accelerating its hydrogen business activities.

Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.

AW Technologies and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, have entered into an exclusive distribution agreement in Japan for AW Technologies’ TrachFlush™ device.